⌘+K

Pulse Explore Communities Researchers Journals

Browser extensionInstagram

Home Communities Explore

April 9, 2024Neurology

Pulmonary Safety of Staccato® Alprazolam in Healthy Participants and Participants with Mild Asthma: Phase 1, Randomized, Double-blind, Placebo-controlled Trial (P9-1.009)

S. David Miller Craig LaForce Laura Barlow Aliceson King Maria Burian Hugues Chanteux

View at Publisher

Ask AI

Bookmark

Share

Ask about this paper

Answers are grounded in this paper and cite their sources.

Ask your own question…

Abstract

Evaluate pulmonary safety of repeat dosing of Staccato® alprazolam (STAP) in healthy participants and those with mild asthma.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Miller et al. (2024) studied this question.

synapsesocial.com/papers/68e6feb4b6db643587678b1d https://doi.org/10.1212/wnl.0000000000204905

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 10 related papers. Consider them for comparative context:

1Pharmacokinetics of Staccato® Alprazolam in Healthy Adult Participants: Phase 1, Randomized, Placebo-controlled Ethno-bridging Study (P9-1.007)2024
2Pharmacokinetics of Staccato<sup>®</sup> alprazolam in healthy adult participants in two phase 1 studies: An open‐label smoker study and a randomized, placebo‐controlled ethnobridging study2024 · 6 citations
3Pharmacokinetics and tolerability of single‐dose Staccato® alprazolam in adolescents with epilepsy, and population pharmacokinetic analysis to support dose selection in adolescentsHuman Clinical Trial · 2025 · 2 citations
4Pharmacokinetics and Tolerability of Single-dose Staccato® Alprazolam in Adolescents with Epilepsy and Population PK Analysis to Support Dose Selection in Adolescents (P9-1.002)2024
5Effects of Alprazolam on Gas Exchange, Breathing Pattern, and Lung Function in COPD Patients with AnxietyBlinded Clinical Trial · 1989
6Alprazolam in the Treatment of Cardiology Patients with Atypical Chest Pain and Panic Disordercase_series · 1988 · 24 citations
7A Fixed-Dose Study of Alprazolam 2 mg, Alprazolam 6 mg, and Placebo in Panic DisorderRCT · 1992 · 48 citations
8Cardiovascular and Symptomatic Reduction Effects of Alprazolam and Imipramine in Patients with Panic Disorder: Results of a Double-Blind, Placebo-Controlled TrialRCT · 1990 · 57 citations
9Statin-induced Myopathy Beyond the Surface: Immune-mediated Necrotizing Myopathy Triggered by CYP3A4 InteractionNeurology · 2026
10Sex Differences in Blood Pressure Dynamics and Outcomes After Endovascular ThrombectomyNeurology · 2026

More from Neurology

More from UCB Pharma (Belgium)

More from Medical Research Associates

More from North Carolina Clinical Research

More from AltaMed